THE HUMAN BETA-3-ADRENOCEPTOR - THE SEARCH FOR A PHYSIOLOGICAL-FUNCTION

[1] BLIN N, IN PRESS MOL PHARM

[2] CHAPMAN BJ, 1988, INT J OBESITY, V12, P119

[3] WEIGHT-LOSS IN OBESE SUBJECTS ON A RESTRICTED DIET GIVEN BRL-26830A, A NEW ATYPICAL BETA-ADRENOCEPTOR AGONIST [J]. BRITISH MEDICAL JOURNAL, 1988, 296 (6631) : 1217 - 1220

[4] EMORINE L J, 1992, American Journal of Clinical Nutrition, V55, p215S, DOI 10.1093/ajcn/55.1.215s

[5] MOLECULAR CHARACTERIZATION OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR [J]. SCIENCE, 1989, 245 (4922) : 1118 - 1121

[6] ESBENSHADE TA, 1992, MOL PHARMACOL, V42, P753

[7] FEVE B, 1991, J BIOL CHEM, V266, P20329

[8] GRANNEMAN JG, 1992, MOL PHARMACOL, V42, P964

[9] GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895

[10] GRANNEMAN JG, 1993, MOL PHARMACOL, V44, P264

[1] BLIN N, IN PRESS MOL PHARM

[2] CHAPMAN BJ, 1988, INT J OBESITY, V12, P119

[3] WEIGHT-LOSS IN OBESE SUBJECTS ON A RESTRICTED DIET GIVEN BRL-26830A, A NEW ATYPICAL BETA-ADRENOCEPTOR AGONIST [J]. BRITISH MEDICAL JOURNAL, 1988, 296 (6631) : 1217 - 1220

[4] EMORINE L J, 1992, American Journal of Clinical Nutrition, V55, p215S, DOI 10.1093/ajcn/55.1.215s

[5] MOLECULAR CHARACTERIZATION OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR [J]. SCIENCE, 1989, 245 (4922) : 1118 - 1121

[6] ESBENSHADE TA, 1992, MOL PHARMACOL, V42, P753

[7] FEVE B, 1991, J BIOL CHEM, V266, P20329

[8] GRANNEMAN JG, 1992, MOL PHARMACOL, V42, P964

[9] GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895

[10] GRANNEMAN JG, 1993, MOL PHARMACOL, V44, P264